Truist Financial’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History
Bought
Maintained
Sold
Other funds holding ECTE
Truist Financial's ECTE Position: Q4 2016 in Review
Truist Financial sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q4 2016, closing a stake of 12,000 shares — an estimated $5K sold.
Truist Financial first reported a position in ECTE in Q2 2013 and held it in 14 quarters. The position peaked at $38K in Q4 2013. 2 funds tracked by Wall St. Rank hold ECTE as of Q4 2016.
- Truist Financial reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q4 2016 after selling out during the quarter.
- Truist Financial sold 12,000 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q4 2016, an estimated $5K.
- Truist Financial first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 14 quarters.
- Truist Financial's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $38K in Q4 2013.
- 2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q4 2016.
Based on Truist Financial's 13F filing for Q4 2016, filed 2 Feb 2017.